ArticleBMC infectious diseases2025
Dual diagnosis of neurobrucellosis and Anti-LGI1 encephalitis: a rare case report.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAnti-LGI1 encephalitis is a subtype of autoimmune encephalitis characterised by cognitive dysfunction, psychiatric disorders, faciobrachial dystonic seizures, and hyponatraemia. However, its precise pathogenesis remains unclear. Brucellosis, a zoonotic disease prevalent globally, poses a significant threat to public health; nevertheless, the nonspecific nature of its clinical symptoms often results in diagnostic delays. CASE PRESENTATION: We report the case of a middle-aged male patient diagnosed with anti-LGI1 antibody encephalitis through antibodies in serum and CSF combined with neurobrucellosis through serum antibodies and CSF NGS. Additional testing for paraneoplastic-related and demyelinating-related antibodies, CSF and blood culture yielded negative results, helping rule out other pathogens and etiologies. The patient exhibited symptom improvement after effective antimicrobial and immunomodulatory therapies.
conclusionsThis case raises awareness of autoimmune encephalitis following Brucella infection, revealing a potential association between Brucella infection and anti-LGI1 antibody encephalitis. Brucella may be a triggering factor for anti-LGI1 antibody encephalitis; however, more cases are needed to confirm our findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.